Maximal Resection of Contrast-Enhanced and Non–Contrast Enhanced Tumors Improves Survival Across Subgroups in Newly Diagnosed Glioblastoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Association of Maximal Extent of Resection of Contrast-Enhanced and Non-Contrast-Enhanced Tumor With Survival Within Molecular Subgroups of Patients With Newly Diagnosed Glioblastoma
JAMA Oncol 2020 Feb 06;2020(-)E1-E9, AM Molinaro, S Hervey-Jumper, RA Morshed, J Young, SJ Han, P Chunduru, Y Zhang, JJ Phillips, A Shai, M Lafontaine, J Crane, A Chandra, P Flanigan, A Jahangiri, G Cioffi, Q Ostrom, JE Anderson, C Badve, J Barnholtz-Sloan, AE Sloan, BJ Erickson, PA Decker, ML Kosel, D LaChance, J Eckel-Passow, R Jenkins, J Villanueva-Meyer, T Rice, M Wrensch, JK Wiencke, NA Oberheim Bush, J Taylor, N Butowski, M Prados, J Clarke, S Chang, E Chang, M Aghi, P Theodosopoulos, M McDermott, MS BergerFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.